Atlas Trials

Trial Investigating the Long Term Safety and Tolerability of Desmopressin Orally Disintegrating Tablets (ODT) for Nocturia Due to Nocturnal Polyuria in Japanese Subjects

Clinical trial NCT03051009 · COMPLETED

Trial details

NCT number
NCT03051009
Sponsor
Ferring Pharmaceuticals
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Nocturia
Start date
2017-01-11
Primary completion
2018-09-11
Enrollment
503

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.